Sanofi Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 11.24B | 12.21B | 13.17B | 10.73B | 10.61B | 7.63B | 14.16B | 11.38B |
| Cost of Goods Sold | 3.14B | 3.63B | 3.41B | 2.99B | 2.89B | 2.27B | 4.08B | 3.41B |
| Gross Profit | 8.11B | 8.57B | 9.76B | 7.74B | 7.72B | 5.36B | 10.07B | 7.97B |
| R&D Expenses | 1.75B | 2.29B | 1.83B | 1.91B | 1.81B | 2.12B | 1.85B | 1.70B |
| Operating Expenses | 5.84B | 9.61B | 6.13B | 6.27B | 5.43B | 4.79B | 6.44B | 6.38B |
| Operating Income | 2.27B | -1.04B | 3.62B | 1.47B | 2.29B | 573.0M | 3.63B | 1.59B |
| Other Income / Gains | -255.0M | -117.0M | -115.0M | -7.0M | -85.0M | -122.0M | -54.0M | -179.0M |
| Net Income | 1.61B | -801.0M | 2.80B | 3.94B | 1.87B | 499.0M | 2.81B | 1.11B |
| EPS (Diluted) | 0.67 | -1.48 | 1.15 | 1.60 | 0.76 | 0.35 | 1.13 | 0.45 |
| Reported Currency | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
| Gross Profit Ratio | 0.721 | 0.703 | 0.741 | 0.721 | 0.728 | 0.702 | 0.711 | 0.70 |
| General And Administrative Expenses | 2.33B | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 167.0M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 2.49B | 2.40B | 2.29B | 2.63B | 2.22B | 1.24B | 2.68B | 2.65B |
| Other Expenses | 1.60B | 4.92B | 2.01B | 1.73B | 1.40B | 1.43B | 1.90B | 2.02B |
| Cost And Expenses | 8.97B | 13.24B | 9.55B | 9.26B | 8.32B | 7.06B | 10.52B | 9.79B |
| Interest Income | 60.0M | 23.7M | 114.0M | 154.8M | 86.0M | 185.0M | 133.0M | 258.8M |
| Interest Expense | 178.0M | -100.6M | 227.0M | 201.4M | 213.0M | 302.1M | 265.0M | 304.2M |
| Depreciation And Amortization | 535.0M | 1.97B | 461.0M | 378.0M | 399.0M | 209.0M | 479.0M | 499.0M |
| Ebitda | 2.72B | 3.82B | 4.20B | 1.89B | 2.77B | 563.0M | 4.25B | 2.03B |
| Ebitdaratio | 0.242 | 0.313 | 0.319 | 0.176 | 0.261 | 0.074 | 0.30 | 0.178 |
| Operating Income Ratio | 0.202 | -0.085 | 0.275 | 0.137 | 0.215 | 0.075 | 0.257 | 0.14 |
| Income Before Tax | 2.01B | -1.16B | 3.51B | 1.47B | 2.20B | 451.0M | 3.58B | 1.42B |
| Income Before Tax Ratio | 0.179 | -0.095 | 0.266 | 0.137 | 0.207 | 0.059 | 0.253 | 0.124 |
| Income Tax Expense | 420.0M | -348.0M | 680.0M | 230.0M | 481.0M | 4.0M | 737.0M | 299.0M |
| Net Income Ratio | 0.144 | -0.066 | 0.213 | 0.367 | 0.177 | 0.065 | 0.199 | 0.098 |
| Epsdiluted | 0.67 | -1.46 | 1.14 | 1.60 | 0.76 | 0.35 | 1.13 | 0.45 |
| Weighted Average Shs Out | 2.41B | 2.44B | 2.44B | 2.47B | 2.47B | 2.51B | 2.51B | 2.50B |
| Weighted Average Shs Out Dil | 2.41B | 2.44B | 2.47B | 2.47B | 2.47B | 2.51B | 2.51B | 2.50B |